Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term Insulin Pump Therapy in T2DM
NCT03509324Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2015
- Primary completion
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin lispro in type 2 diabetes mellitus (T2DM), sponsored by Sun Yat-sen University. Primary endpoint: Fasting Plasma Glucose at 10 hour. Started Mar 2015; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03509324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03509324.